ロード中...
BRCA Genetic Test and Risk-Reducing Salpingo-Oophorectomy for Hereditary Breast and Ovarian Cancer: State-of-the-Art
SIMPLE SUMMARY: The BRCA genetic test and HRD (homologous recombination deficiency) test are used as a companion diagnosis before starting PARP (poly ADP-ribose polymerase) inhibitor treatment. In clinical practice, gynecologists treating ovarian cancer are faced with decisions such as whether to re...
保存先:
| 出版年: | Cancers (Basel) |
|---|---|
| 主要な著者: | , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
MDPI
2021
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8197088/ https://ncbi.nlm.nih.gov/pubmed/34071148 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers13112562 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|